搜索临床试验以:Tyrosine Kinase inhibitor (TKI)
总计68203个结果
-
Shenzhen People's Hospital未知
-
Spanish Lung Cancer Group完全的
-
Tongji HospitalWuhan University; Hubei Cancer Hospital; Wuhan Union Hospital, China; Renmin Hospital of Wuhan University完全的
-
Zhejiang University未知
-
Cancer Institute and Hospital, Chinese Academy...未知非小细胞肺癌 | III 期非小细胞肺癌 | EGFR突变相关肿瘤
-
Medical College of WisconsinMemorial Sloan Kettering Cancer Center; Dana-Farber Cancer Institute; University of Chicago; Emory... 和其他合作者完全的
-
xunaNanfang Hospital of Southern Medical University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen... 和其他合作者撤销
-
Poitiers University Hospital招聘中
-
Nanfang Hospital of Southern Medical UniversityGuangxi Medical University; Peking University People's Hospital; Sun Yat-Sen Memorial Hospital... 和其他合作者未知
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
University Health Network, Toronto未知
-
Telios Pharma, Inc.完全的
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte Corporation; H. Jean Khoury Cure CML Consortium招聘中
-
Bayer完全的2019 冠状病毒病 (COVID-19) | SARS-CoV-2 感染 | 恶性实体瘤美国
-
Lady Davis InstituteJewish General Hospital未知
-
The First Affiliated Hospital of Soochow University完全的急性髓性白血病 | 急性淋巴细胞白血病 | 慢性粒细胞白血病 | 费城染色体 | 混合表型急性白血病中国
-
Nanfang Hospital of Southern Medical UniversityPeking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen Memorial Hospital... 和其他合作者未知同种异体造血干细胞移植 | 最小残留病 | 费城染色体阳性急性淋巴细胞白血病 | 酪氨酸激酶抑制剂中国
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdSunshine Lake Pharma Co., Ltd.终止
-
University Hospital, Bordeaux招聘中在使用 PD1/PDL1 ICIs + VEGFR-酪氨酸激酶抑制剂治疗 12 个月时有客观反应的 mRCC 患者中只有一个不良预后因素的 IMDC 良好或中等风险的治疗暂停与治疗继续 (SPICI)转移性肾细胞癌 | 每个 IMDC 评分的良好或只有一个不良预后因素中等风险法国
-
Tata Memorial Hospital招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySuzhou Suncadia Biopharmaceuticals Co., Ltd.招聘中
-
Li Zhang, MD招聘中诊断为 ALK 阳性 NSCLC | 第二代 ALK-TKI 耐药 | Ensatinib 在这部分患者中的疗效中国
-
Nanfang Hospital of Southern Medical University招聘中
-
National Research Center for Hematology, Russia主动,不招人